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Patients: Surgical Challenges and Clinical Outcomes
W. Zhou, M. Reardon, E.K. Peden, P.H. Lin and A.B. Lumsden
Background. Endovascular therapy is a less invasive alternative treatment
for high-risk patients with thoracic aortic aneurysms. However, this technol-
ogy alone is often not applicable to complex aneurysmal morphology. The
purpose of this study was to evaluate the utility of hybrid strategies in
high-risk patients who are otherwise unsuitable for endovascular therapy
alone.
Methods. During an 18-month period, 31 high-risk patients (mean age, 69
years; range, 52-89 years) underwent combined open and endovascular ap-
proaches for complex aneurysms, including 16 patients with ascending and
arch aneurysms and 15 patients with aneurysms involving visceral vessels.
Among them, 11 patients had histories of aneurysm repairs. To overcome
the anatomic limitations of endovascular repairs, various adjunctive surgical
maneuvers were used, including aortic arch reconstruction in 3 patients, su-
pra-aortic trunk debranching in 13 patients (including 8 patients who re-
quired aortas as inflow sources), and visceral vessel bypasses in 15 patients
(including 10 patients who required bypasses to all 3 visceral branches). Ad-
ditionally, carotid artery access was obtained in 1 patient, and iliac artery con-
duits were created in 12 patients.
Results. Technical success was achieved in all patients. There was one perio-
perative death (3.2%) due to postoperative bleeding. Two patients (6.4%) had
immediate type II endoleaks, which were resolved by the 1-month follow-up.
Other procedure-related complications occurred in three patients (9.6%), in-
cluding renal bypass thromboses in two patients and retroperitoneal hema-
toma, which was successfully managed conservatively, in one patient.
During a mean follow-up of 16 months, two patients died of unrelated
causes, whereas the remainder of patients were asymptomatic, without aneu-
rysm enlargement.
Conclusions. Our study highlights how hybrid strategies incorporating surgi-
cal and endovascular approaches can be used successfully in treating patients
with complex thoracic aortic aneurysms. This combined approach potentially
expands the field of endovascular stent grafting and is an attractive solution
for patients with poor cardiopulmonary reserves.
Sac Behavior after Aneurysm Treatment with the Gore Excluder Low-
Permeability Aortic Endoprosthesis: 12-month Comparison to the
Original Excluder Device
Shan-e-ali Haider, S.F. Najjar, J.-S. Cho, R.Y. Rhee, M.K. Eskandari, J.S.
Matsumura, M.S. Makaroun and M.D. Morasch
Background. The original Gore Excluder endoprosthesis (OGE) used both
during and briefly after clinical trials was associated with less sac regression
and more sac growth than some other devices, even without apparent endo-
leaks, presumably because of transmural movement of serous fluid across the
expanded polytetrafluoroethylene material. In July 2004, the device was mod-
ified to decrease graft permeability. This study evaluated the efficacy of the
new Excluder Low-Permeability Device (ELPD) at 1 year and compared it
with the OGE and the Cook Zenith device (ZEN).
Methods. From Food and Drug Administration approval of the Excluder in
November 2002 until June 2005, 283 patients underwent endovascular repair
of abdominal aortic aneurysms with the Gore Excluder or the ZEN. Post-
operative surveillance included computed tomographic scans at 1 and 12
months; 181 (64%)patients completedboth scans.The1-month computed tomo-
graphic scan served as a baseline, and theminor axis diameter, measured at the
largest axial cut of the abdominal aortic aneurysm,was comparedwith the same
measurement at 1 year. A sac size change of 5 mm or more was considered sig-
nificant. Sixty patients treated with the OGE were compared with 72 patients
treated with the ELPD. Forty-nine patients treated during the same time period
with the ZEN, known for early sac shrinkage, were used as a reference. AllYEJVS2263_2246_proof  2
1078e5884/000346 + 03 $35.00/0  2006 Published by Elsevier Ltd.measurementswere performedbyone observer fromadigitalworkstation.Wil-
coxon signed rank tests (pairwise) or Kruskal-Wallis tests (three groups) were
used for intergroup comparison of continuous variables, whereas c2 statistics
or Fisher exact tests were used to compare categorical variables.
Results. Patient age and sex and mean maximum aneurysm diameter at base-
line were similar among groups (P ¼ .59, .27, and .46, respectively). Graft mi-
gration, stent fractures, acute surgical conversion, late abdominal aortic
aneurysm rupture, or aneurysm-related deaths were not observed. Type II
endoleak rates were similar between ELPD and ZEN (23.6% and 20.4%;
P ¼ .68). Although a higher rate of endoleaks was seen with OGE (36.7%),
this was not significant when compared with the other two devices
(P ¼ .11). At 1 year, patients treated with ELPD had a sac regression rate
that was significantly higher than that for patients treated with OGE (63.9%
vs 25%; P < 0.001) and was similar to that for patients treated with ZEN
(65.3%). Significant sac expansion was not observed with ELPD.
Conclusions. At 1 year, similar to ZEN, significant aneurysm sac regression
and minimal sac expansion were noted after endovascular repair of abdom-
inal aortic aneurysms with ELPD. Low-porosity fabric used in the construc-
tion of endoprostheses seems to be an important factor in early aneurysm sac
shrinkage. Long-term efficacy regarding the prevention of sac enlargement
remains unclear, and further follow-up is suggested.
Management of Aneurysms Involving Branches of the Celiac and
Superior Mesenteric Arteries: A Comparison of Surgical and
Endovascular Therapy
U. Sachdev, D.T. Baril, S.H. Ellozy, R.A. Lookstein, D. Silverberg,
T.S. Jacobs, A. Carroccio, V.J. Teodorescu and M.L. Marin
Objective. Aneurysms involving branches of the superior mesenteric and ce-
liac arteries are uncommon and require proper management to prevent rup-
ture and death. This study compares surgical and endovascular treatment of
these aneurysms and analyzes outcome.
Methods. Patients at the Mount Sinai Medical Center in New York who were
treated for aneurysms in the branches of the celiac artery and superior mes-
enteric artery were identified through a search of the institution’s medical re-
cords and endovascular database. Patient demographics, history, clinical
presentation, aneurysm characteristics, treatments, and follow-up outcome
were retrospectively recorded. Significant differences between patients
treated by surgical or endovascular therapy were determined by using Stu-
dent’s t test and c2 analysis.
Results. Between January 1, 1991, and July 1, 2005, 59 patients with 61 aneu-
rysmswere treated at a single institution. Twenty-four patients had surgical re-
pair, and 35 underwent endovascular treatment, which included coil
embolization and stent-graft therapy. Splenic (28) and hepatic (22) artery aneu-
rysms predominated. Eighty-nine percent of splenic artery aneurysms were
true aneurysms and were treated by endovascular and surgical procedures in
near equal numbers (14 and 11, respectively). Pseudoaneurysms were signifi-
cantly more likely to be treated by endovascular means (P< .01). The technical
success rate of endovascular treatment for aneurysms was 89%, and failures
were successfully treated by repeat coil embolization in all patients who pre-
sented for retreatment. Patients treated by endovascular techniques had a sig-
nificantly higher incidence of malignancy than patients treated with open
surgical techniques (P ¼ .03). Furthermore, patients treated by endovascular
means had a shorter in-hospital length of stay (2.4 vs 6.6 days, P < .001).
Conclusion. Endovascular management of visceral aneurysms is an effective
means of treating aneurysms involving branches of the celiac and superior
mesenteric arteries and is particularly useful in patients with comorbidities,
including cancer. It is associated with a decreased length of stay in the elec-
tive setting, and failure of primary treatment can often be successfully man-
aged percutaneously.5 October 2006  346/348
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347AbstractsAutologous Bone-marrow Mononuclear Cell Implantation for Patients
with Rutherford Grade II-III Thromboangiitis Obliterans
S. Durdu, A.R. Akar, M. Arat, T. Sancak, N.T. Eren and U. Ozyurda
Background. This study investigated the efficacy and safety of autologous bone
marrow-mononuclear cells (ABMMNC) implantation in patients with critical
limb ischemia (CLI) due to thromboangiitis obliterans (Buerger’s disease).
Methods. The study comprised 28 patients (25 men and 3 women) with a me-
dian age of 44 years (range, 25e54 years) who had thromboangiitis obliterans
and unilateral critical limb ischemia, defined as ischemic rest pain in a limb
with or without nonhealing ulcers. The patients received multiple injections
of erythrocyte-depleted and volume-reduced ABMMNC into the gastrocne-
mius muscle, the intermetatarsal region, and the feet dorsum (n ¼ 26) or fore-
arm (n ¼ 2) vs saline injections into the less ischemic contralateral limbs. The
patients were nonresponders to previous Iloprost infusion and smoking ces-
sation 6 months and were not candidates for nonsurgical or surgical revas-
cularization. Primary end points were the total healing of the most important
lesion while avoiding major or minor amputation, the relief of rest pain with-
out the need for analgesics from baseline to 6 months’ follow-up, and the
safety and feasibility of the treatment. Secondary end points were the changes
in ankle-brachial pressure index and peak walking time, the angiographic ev-
idence of collateral vessel formation or remodeling, and the quality-of-life as-
sessment. Two investigators blinded for treatment assignment performed
image analyses.
Results. Unilateral intramuscular administration of ABMMNC was not asso-
ciated with any complications. The mean follow-up time was 16.6  7.8
months (range, 7.6 to 33.8 months). Only one patient required toe amputation
during follow-up. A change in the ankle-brachial pressure index >0.15 was
achieved in 8 patients at 3 months and in 14 patients at 6 months compared
with baseline values. At 6 months, patients demonstrated a significant im-
provement in rest pain scores (P < .0001), peak walking time (P < .0001),
and quality of life (P < .0083). Total healing of the most important lesion
was achieved in 15 patients (83%) with ischemic ulcers, and relief of rest
pain without the need of narcotic analgesics improved in all patients. Digital
subtraction angiography studies before and 6 months after the ABMMNC im-
plantation showed vascular collateral networks had formed across the af-
fected arteries in 22 patients (78.5%).
Conclusions. ABMMNC implantation could be a safe alternative to achieve
therapeutic angiogenesis in patients with thromboangiitis obliterans and crit-
ical limb ischemia refractory to other treatment modalities.
Early Biomechanical Changes in Lower Extremity Vein GraftsdDistinct
Temporal Phases of Remodeling and Wall Stiffness
C.D. Owens, N. Wake, J.G. Jacot, M. Gerhard-Herman, P. Gaccione,
M. Belkin, M.A. Creager and M.S. Conte
Background. The geometric and biomechanical changes that contribute to
vein graft remodeling are not well established. We sought to measure pat-
terns of adaptation in lower extremity vein grafts and assess their correlation
with clinical outcomes.
Methods. We conducted a prospective, longitudinal study of patients under-
going infrainguinal reconstruction with autogenous conduit. In addition to
standard duplex surveillance, lumen diameter (of a defined index segment
of the conduit) and pulse wave velocity (PWV) were assessed by ultrasound
imaging at surgery and at 1, 3, and 6 months postoperatively. Graft dimen-
sions and wall stiffness were correlated with clinical outcomes.
Results. There were 92 patients and 96 limbs in this study. On average, vein
graft lumen diameter increased during the first month of implantation from
0.37 .01 cm to 0.45 0.02 cm (mean SEM; P¼ .002), representing a relative
change of þ21.6% (median  14%; range, 31 to þ67%) during this period. Of
the entire cohort, 72% of grafts demonstrated appreciable dilation of the index
segment during the firstmonth. Index segment lumen diameter did not change
appreciably beyond 1 month, with the notable exception of arm vein conduits,
which showed continued tendency to dilate. PWV increased during the first 6
months (17.2  1.2 m/s to 23.2  2.4 m/s; P ¼ .008), reflecting a nearly 40% in-
crease in conduit stiffness (2.0 .6Mdynes/cm to 3.3 .8Mdynes/cm,P¼.01).
The greatest relative increase (25%) inPWVoccurred frommonths 1 to 3. Loss of
primary patency occurred in 24 cases (19 revisions, 5 occlusions), with a mean
reintervention time of 7.6 months. Grafts that demonstrated early positive
remodeling (lumen dilatation) had a trend of increased primary patency(P ¼ .08, log rank). Among the grafts that failed, a trend was noted toward
greater wall stiffness at 1 month, 2.7 vs 1.5 Mdynes (P ¼ .08).
Conclusion. Vein graft remodeling appears to involve at least two distinct
temporal phases. Outward remodeling of the lumen occurs early, and wall
stiffness changes occur in a more delayed fashion. Early outward remodeling
may be important for successful vein graft adaptation.
Determinants of Functional Outcome after Revascularization for Critical
Limb Ischemia: An Analysis of 1000 Consecutive Vascular Interventions
S.M. Taylor, C.A. Kalbaugh, D.W. Blackhurst, A.L. Cass, E.A. Trent,
E.M. Langan and J.R. Youkey
Background. When reporting standards for successful lower extremity revas-
cularization were established, it was assumed that arterial reconstruction, pa-
tency, and limb salvage would correlate with the ultimate goal of therapy:
improved functional performance. In reality, factors determining improve-
ment of ambulation and maintenance of independent living status after re-
vascularization have been poorly studied. The purpose of this study was to
assess the important determinants of functional outcome for patients after
intervention for critical limb ischemia.
Methods. The results of 1000 revascularized limbs from841 patientswere stud-
ied. Indications were rest pain, 41.1%; ischemic ulceration, 35.6%; gangrene,
23.3%; infrainguinal, 70.9%; aortoiliac, 24.2%; and both, 4.9%. Treatment was
by endovascular intervention, 35.5%; open surgery, 61.7%; and both, 2.8%. Pa-
tient were mean age of 68  12 years, and 56.6% were men, 74.7% were white,
54.2% had diabetesmellitus, 67%were smokers, 13.4% had end-stage renal dis-
ease and were on dialysis, and 36% had prior vascular surgery. Patients were
treated with conventional therapy by fellowship-trained vascular specialists
at a single center and were analyzed according to the type of intervention,
the arterial level treated, age, race, gender, presentation, the presence of diabe-
tes, smoking history, end-stage renal disease, coronary disease, hypertension,
hyperlipidemia, obesity, chronic obstructive pulmonary disease, previous
stroke, dementia, prior vascular surgery, preoperative ambulatory status,
limb loss 1 year of treatment, and independent living status. The technical
outcomes of reconstruction patency and limb salvage as well as the functional
outcomes of survival, maintenance of ambulation, and independent living sta-
tus were measured for each variable using Kaplan-Meier life-table analysis,
and differences were assessed using the log-rank test. A Cox proportional haz-
ards model was used to assess independent predictors of outcome and obtain
adjusted hazard ratios and 95% confidence intervals.
Results. At 5 years, 72.4% of the entire cohort had a patent reconstruction and
72.1% had an intact limb. Overall 5-year functional outcomes were 41.9% for
survival, 70.6% formaintenance of ambulation, and 81.3% for independent liv-
ing status. Outcomewas not significantly affected by the type of treatment (en-
dovascular or open surgery) or by the level of disease treated (aortoiliac,
infrainguinal, or both). The most important independent, statistically signifi-
cant predictors of particularly poor functional outcome were impaired ambu-
latory ability at the time of presentation (70% 5-year mortality, hazard ratio,
3.34; 39.5% failure to eventually ambulate, hazard ratio, 2.83; 30% loss of inde-
pendent living status, hazard ratio, 7.97), and the presence of dementia (73%
late mortality, hazard ratio, 1.57; 41.2% failure to eventually ambulate, hazard
ratio, 2.20; 46.4% loss of independent living status, hazard ratio, 5.44). These
factors were even more predictive than limb amputation alone.
Conclusion. Functional outcome for patients undergoing intervention for crit-
ical limb ischemia is not solely determined by the traditional measures of re-
construction patency and limb salvage, but also by certain intrinsic patient
comorbidities at the time of presentation. These findings question the benefit
of our current approach to critical limb ischemia in functionally impaired,
chronically ill patientsdpatients who undoubtedly will be more prevalent
as our population ages.
Predicting Adverse Outcome in Outpatients with Acute Deep Vein
Thrombosis. Findings from the RIETE Registry
J. Trujillo-Santos, S. Herrera, M.A. Page, M.J. Soto, A. Ravento´s, R. Sa´nchez,
M. Monreal and the RIETE Investigators
Background. Home treatment of patients with acute deep vein thrombosis
(DVT) leads to cost savings and improved quality of life. However, little
348 Abstractsinformation is known about what influences the clinical outcome in these
patients.
Methods. The Registro Informatizado de la Enfermedad TromboEmbo´lica
(RIETE) is an ongoing registry of consecutive patients with symptomatic, ob-
jectively confirmed, acute DVT or pulmonary embolism (PE). In this analysis
evaluated the clinical outcome 15 days of the start of therapy of all enrolled
outpatients with acute DVT in the lower limbs.
Results. During the study period, 124 (2.8%) of 4405 DVT patients had at least
one adverse event (symptomatic PE, 15; recurrent DVT, 18; major bleeding,
37; death, 68). On multivariate analysis, bilateral DVT, renal insufficiency,
body weight <70 kg, recent immobility, chronic heart failure, and cancer
were associated with an increased risk for adverse events. When these vari-
ables were added into the derivation sample, the area under receiver operator
characteristic (ROC) curve was 0.81 (95% confidence interval [CI], 0.76 to
0.86). Patients with a risk score of 2 had a 1.2% incidence of adverse events
(23 in 1935 patients) compared with the 6.8% incidence in high-risk patients.
In the validation sample, the area under ROC curve was 0.79 (95% CI, 0.70 to
0.88). Low-risk patients had a 1.0% incidence of adverse events, and those at
high-risk had a 4.7% incidence.
Conclusion. A simple risk score based on easily available variables can iden-
tify DVT outpatients at low risk for an adverse outcome. This information
may help clinicians to decide which DVT patients may be eligible for ambu-
latory treatment.
Obstructive Lesions of the Inferior Vena Cava: Clinical Features and
Endovenous Treatment
S. Raju, K. Hollis and P. Neglen
Objective. Chronic obstructions of the inferior vena cava (IVC) are associated
with many odd features. Even total occlusions may remain entirely silent or
present late with acute symptoms. Renal dysfunction is rare. Many haveEur J Vasc Endovasc Surg Vol 32, October 2006chronic symptoms, but often only one limb is affected. We describe the clin-
ical features in a series of 120 patients seen over a 10-year period and the re-
sults of successful stent placement in 99 limbs.
Methods. Patients with acute onset of symptoms due to distal thromboses un-
derwent catheter-directed thrombolysis. Patients with significant chronic
symptoms were investigated by duplex, venous function tests, transfemoral
venography and finally intravascular ultrasound (IVUS). Stenotic segments
were balloon dilated and occluded segments were recannalized when feasi-
ble; stents were placed under IVUS control.
Results. In the asymptomatic group, 10 patients with total occlusions had
transient or no occlusive symptoms. In the acute symptom group, four pa-
tients with chronic IVC occlusions presented with acute onset of deep ve-
nous thrombosis distal to the occlusion but became asymptomatic when
the clot was lysed. In the chronic symptom group, 97 patients (99 limbs)
had symptoms of chronic venous disease of variable distribution and in-
tensity. In two-thirds, limb symptoms were unilateral. Pathology was total
occlusion in 14%, and the rest were stenoses. The lesion extended above
the renal vein in 18%. Common iliac obstruction was concurrent in 93%.
Distal reflux was present in 66%. Modifications of the basic stent technique
were required in recanalization of total occlusions (four extending up to
the atrium), two bilateral stent deployments, and nine IVC filter cases.
Stent deployment across the renal and hepatic veins or the contralateral
iliac vein had no adverse sequelae. Stent patency (cumulative) at 2 years
was 82%. Complete relief (cumulative) of pain and swelling at 3.5 years
was 74% and 51%, respectively. The cumulative rate of complete ulcer
healing at 2 years was 63%. Overall clinical outcome was rated as good
or excellent in 70%.
Conclusions. The unusual clinical features of IVC obstructions seem related
to the rich collateralization, which has an embryonic basis. Common iliac
vein patency seems to be a crucial link in collateral function, and its concur-
rent occlusion produces symptoms. Percutaneous stent placement has an
emerging role in the treatment of IVC obstructive lesions, with good mid-
term stent patency and clinical results.
